During the past decade, Kozni ambulance Kutna Hora, s.r.o. conducted 8 clinical trials. In the 10-year time frame, 8 clinical trials started and 6 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 6 clinical trials were completed. i.e. 300% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Kozni ambulance Kutna Hora, s.r.o." #1 collaborator was "Incyte Corporation" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Kozni ambulance Kutna Hora, s.r.o." are "Psoriasis" (3 trials), "Atopic Dermatitis" (2 trials), "Dermatitis, Atopic" (2 trials) and "Palmoplantar Pustulosis" (1 trials). Many other conditions were trialed in "Kozni ambulance Kutna Hora, s.r.o." in a lesser frequency.

Most popular intervention types in "Kozni ambulance Kutna Hora, s.r.o." are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (7 trials), "Mirikizumab" (2 trials), "Secukinumab" (2 trials), "Abrocitinib 100 mg" (1 trials) and "Abrocitinib 200 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "Kozni ambulance Kutna Hora, s.r.o." are 8 trials for "All" genders.

Currently, there are NaN active trials in "Kozni ambulance Kutna Hora, s.r.o.". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Kozni ambulance Kutna Hora, s.r.o., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Kozni ambulance Kutna Hora, s.r.o., 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".